Viral vectors for gene delivery to the central nervous system

Thomas B. Lentz, Steven J. Gray, R. Jude Samulski

Research output: Contribution to journalReview article

124 Citations (Scopus)

Abstract

The potential benefits of gene therapy for neurological diseases such as Parkinson's, Amyotrophic Lateral Sclerosis (ALS), Epilepsy, and Alzheimer's are enormous. Even a delay in the onset of severe symptoms would be invaluable to patients suffering from these and other diseases. Significant effort has been placed in developing vectors capable of delivering therapeutic genes to the CNS in order to treat neurological disorders. At the forefront of potential vectors, viral systems have evolved to efficiently deliver their genetic material to a cell. The biology of different viruses offers unique solutions to the challenges of gene therapy, such as cell targeting, transgene expression and vector production. It is important to consider the natural biology of a vector when deciding whether it will be the most effective for a specific therapeutic function. In this review, we outline desired features of the ideal vector for gene delivery to the CNS and discuss how well available viral vectors compare to this model. Adeno-associated virus, retrovirus, adenovirus and herpesvirus vectors are covered. Focus is placed on features of the natural biology that have made these viruses effective tools for gene delivery with emphasis on their application in the CNS. Our goal is to provide insight into features of the optimal vector and which viral vectors can provide these features.

Original languageEnglish (US)
Pages (from-to)179-188
Number of pages10
JournalNeurobiology of Disease
Volume48
Issue number2
DOIs
StatePublished - Nov 1 2012

Fingerprint

Viral Genes
Central Nervous System
Genetic Therapy
Genes
Viruses
Dependovirus
Herpesviridae
Amyotrophic Lateral Sclerosis
Retroviridae
Nervous System Diseases
Transgenes
Adenoviridae
Epilepsy
Therapeutics

Keywords

  • Adeno-associated virus
  • Adenovirus
  • Central nervous system
  • Gene therapy
  • Herpesvirus
  • Retrovirus
  • Viral vectors

ASJC Scopus subject areas

  • Neurology

Cite this

Viral vectors for gene delivery to the central nervous system. / Lentz, Thomas B.; Gray, Steven J.; Samulski, R. Jude.

In: Neurobiology of Disease, Vol. 48, No. 2, 01.11.2012, p. 179-188.

Research output: Contribution to journalReview article

Lentz, Thomas B. ; Gray, Steven J. ; Samulski, R. Jude. / Viral vectors for gene delivery to the central nervous system. In: Neurobiology of Disease. 2012 ; Vol. 48, No. 2. pp. 179-188.
@article{de9ed9ea258045c694aed81ca99c5956,
title = "Viral vectors for gene delivery to the central nervous system",
abstract = "The potential benefits of gene therapy for neurological diseases such as Parkinson's, Amyotrophic Lateral Sclerosis (ALS), Epilepsy, and Alzheimer's are enormous. Even a delay in the onset of severe symptoms would be invaluable to patients suffering from these and other diseases. Significant effort has been placed in developing vectors capable of delivering therapeutic genes to the CNS in order to treat neurological disorders. At the forefront of potential vectors, viral systems have evolved to efficiently deliver their genetic material to a cell. The biology of different viruses offers unique solutions to the challenges of gene therapy, such as cell targeting, transgene expression and vector production. It is important to consider the natural biology of a vector when deciding whether it will be the most effective for a specific therapeutic function. In this review, we outline desired features of the ideal vector for gene delivery to the CNS and discuss how well available viral vectors compare to this model. Adeno-associated virus, retrovirus, adenovirus and herpesvirus vectors are covered. Focus is placed on features of the natural biology that have made these viruses effective tools for gene delivery with emphasis on their application in the CNS. Our goal is to provide insight into features of the optimal vector and which viral vectors can provide these features.",
keywords = "Adeno-associated virus, Adenovirus, Central nervous system, Gene therapy, Herpesvirus, Retrovirus, Viral vectors",
author = "Lentz, {Thomas B.} and Gray, {Steven J.} and Samulski, {R. Jude}",
year = "2012",
month = "11",
day = "1",
doi = "10.1016/j.nbd.2011.09.014",
language = "English (US)",
volume = "48",
pages = "179--188",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Viral vectors for gene delivery to the central nervous system

AU - Lentz, Thomas B.

AU - Gray, Steven J.

AU - Samulski, R. Jude

PY - 2012/11/1

Y1 - 2012/11/1

N2 - The potential benefits of gene therapy for neurological diseases such as Parkinson's, Amyotrophic Lateral Sclerosis (ALS), Epilepsy, and Alzheimer's are enormous. Even a delay in the onset of severe symptoms would be invaluable to patients suffering from these and other diseases. Significant effort has been placed in developing vectors capable of delivering therapeutic genes to the CNS in order to treat neurological disorders. At the forefront of potential vectors, viral systems have evolved to efficiently deliver their genetic material to a cell. The biology of different viruses offers unique solutions to the challenges of gene therapy, such as cell targeting, transgene expression and vector production. It is important to consider the natural biology of a vector when deciding whether it will be the most effective for a specific therapeutic function. In this review, we outline desired features of the ideal vector for gene delivery to the CNS and discuss how well available viral vectors compare to this model. Adeno-associated virus, retrovirus, adenovirus and herpesvirus vectors are covered. Focus is placed on features of the natural biology that have made these viruses effective tools for gene delivery with emphasis on their application in the CNS. Our goal is to provide insight into features of the optimal vector and which viral vectors can provide these features.

AB - The potential benefits of gene therapy for neurological diseases such as Parkinson's, Amyotrophic Lateral Sclerosis (ALS), Epilepsy, and Alzheimer's are enormous. Even a delay in the onset of severe symptoms would be invaluable to patients suffering from these and other diseases. Significant effort has been placed in developing vectors capable of delivering therapeutic genes to the CNS in order to treat neurological disorders. At the forefront of potential vectors, viral systems have evolved to efficiently deliver their genetic material to a cell. The biology of different viruses offers unique solutions to the challenges of gene therapy, such as cell targeting, transgene expression and vector production. It is important to consider the natural biology of a vector when deciding whether it will be the most effective for a specific therapeutic function. In this review, we outline desired features of the ideal vector for gene delivery to the CNS and discuss how well available viral vectors compare to this model. Adeno-associated virus, retrovirus, adenovirus and herpesvirus vectors are covered. Focus is placed on features of the natural biology that have made these viruses effective tools for gene delivery with emphasis on their application in the CNS. Our goal is to provide insight into features of the optimal vector and which viral vectors can provide these features.

KW - Adeno-associated virus

KW - Adenovirus

KW - Central nervous system

KW - Gene therapy

KW - Herpesvirus

KW - Retrovirus

KW - Viral vectors

UR - http://www.scopus.com/inward/record.url?scp=84865570079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865570079&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2011.09.014

DO - 10.1016/j.nbd.2011.09.014

M3 - Review article

C2 - 22001604

AN - SCOPUS:84865570079

VL - 48

SP - 179

EP - 188

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 2

ER -